BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20180606T110000
DTEND;TZID=Europe/London:20180606T153000
DTSTAMP:20260413T174825
CREATED:20180424T083626Z
LAST-MODIFIED:20180424T083626Z
UID:17812-1528282800-1528299000@staging.medilinkmidlands.com
SUMMARY:Medical Device Clinical Strategy & Requirements Workshop
DESCRIPTION:Clinical strategy\, evidence and evaluation are central to product approval and market access. It’s a requirement of the new EU Medical Device Regulation (MDR: article 61) that a medical device company have a regulatory strategy and of the MDR and MEDDEV 2.7/1 rev 4 that the company have a clinical evaluation strategy. \nIn order to generate sales\, organisations need to have thought through the clinical elements for market access as this will put them back months\, if not years\, if not understood and completed when initially gathering clinical evidence. \nCompanies need to be prepared and have solutions in place to address this and their ongoing clinical requirements. Getting your clinical strategy wrong will delay approval and also access. \nLearning Outcomes \n• Understand the clinical strategy and how that fits within an overall company strategy\n• Understand the role of clinical investigations\, evaluations\, evidence and post market clinical follow ups\n• Understand how clinical evidence and the role of clinical strategy enables market access\n• Interact with fellow practitioners and presenters during the Q&A \nDelegate Fees \nSEHTA members: £125 + VAT \nNon-members: £175 + VAT \nTo find out more information or register your place\, please click here.
URL:https://staging.medilinkmidlands.com/event/medical-device-clinical-strategy-requirements-workshop/
LOCATION:Hempsons\, 100 Wood Street\, London\, EC2V 7AN\, United Kingdom
END:VEVENT
END:VCALENDAR